Solomon Kattar
Inventor
Stats
- 12 US patents issued
- 16 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 12 US Patents Issued
- 16 US Applications Filed
- 155 Total Citation Count
- Sep 1, 2021 Most Recent Filing
- Jun 21, 2006 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
MSD K.K. | 2
| 2009
|
MERCK SHARP & DOHME LTD. | 1
| 2013
|
MERCK CANADA INC. | 5
| 2010
|
MERCK SHARP & DOHME CORP. | 4
4 4 2 5 4 | 2006
2007 2008 2009 2010 2013 |
Inventor Addresses
Address | Duration |
---|---|
Arlington, MA, US | Sep 24, 09 - May 27, 14 |
Wakefield, MA, US | Mar 05, 13 - Sep 28, 23 |
Technology Profile
Technology | Matters | |
---|---|---|
A01N: | PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF | 1 |
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 14 |
A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 9 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
2023/0303,540 | 2023 | 2-AMINOQUINAZOLINES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF | 0 |
11161854 | 2021 | Indazolyl-spiro[2.2]pentane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof | 1 |
2021/0188,863 | 2021 | INDAZOLYL-SPIRO[2.2]PENTANE-CARBONITRILE DERIVATIVES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF | 0 |
9938281 | 2018 | Purine inhibitors of human phosphatidylinositol 3-kinase delta | 0 |
9730940 | 2017 | Purine inhibitors of human phosphatidylinositol 3-kinase delta | 1 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.